PRNB - Principia Biopharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue69,1375,247-
Cost of Revenue---
Gross Profit69,1375,247-
Operating Expenses
Research Development40,53325,39022,290
Selling General and Administrative11,4626,4434,763
Non Recurring---
Others---
Total Operating Expenses51,99531,83327,053
Operating Income or Loss17,142-26,586-27,053
Income from Continuing Operations
Total Other Income/Expenses Net372-2,111-3,585
Earnings Before Interest and Taxes17,142-26,586-27,053
Interest Expense--7,223-3,898
Income Before Tax18,167-28,697-30,638
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops18,167-28,697-30,638
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income18,167-28,697-30,638
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares4,917-28,697-30,638